Acquisition Announced

Scancell Holdings acquisition of Neuphoria Therapeutics

Announced 23 Jul 2026 · NASDAQ: NEUP

Advisers

Neuphoria Therapeutics

Target

Legal adviser

Scancell Holdings

Acquirer

Financial adviser
Legal adviser
Target
Neuphoria Therapeutics
Acquirer
Scancell Holdings
Target based in
United States
Buyer based in
United Kingdom
Sector
Biotech
Tags
Biotech, Behavioral Health

In the league tables

Similar deals

All biotech deals →

Sources

Suggest a correction

A missing adviser, a wrong role or a different outcome. A link to a public source helps.